Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1984 Aug;50(2):231–233. doi: 10.1038/bjc.1984.168

Decreased natural killer cell activity and interferon production by leucocytes in patients with adenocarcinoma of the pancreas.

K Funa, B Nilsson, G Jacobsson, G V Alm
PMCID: PMC1976881  PMID: 6466540

Full text

PDF
231

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bloom B. R. Interferons and the immune system. Nature. 1980 Apr 17;284(5757):593–595. doi: 10.1038/284593a0. [DOI] [PubMed] [Google Scholar]
  2. Droller M. J., Schneider M. U., Perlmann P. A possible role of prostaglandins in the inhibition of natural and antibody-dependent cell-mediated cytotoxicity against tumor cells. Cell Immunol. 1978 Aug;39(1):165–177. doi: 10.1016/0008-8749(78)90091-6. [DOI] [PubMed] [Google Scholar]
  3. Funa K., Alm G. V., Rönnblom L., Oberg K. Evaluation of the natural killer cell-interferon system in patients with mid-gut carcinoid tumours treated with leucocyte interferon. Clin Exp Immunol. 1983 Sep;53(3):716–724. [PMC free article] [PubMed] [Google Scholar]
  4. Herberman R. B. Immunoregulation and natural killer cells. Mol Immunol. 1982 Oct;19(10):1313–1321. doi: 10.1016/0161-5890(82)90299-1. [DOI] [PubMed] [Google Scholar]
  5. Kadish A. S., Doyle A. T., Steinhauer E. H., Ghossein N. A. Natural cytotoxicity and interferon production in human cancer: deficient natural killer activity and normal interferon production in patients with advanced disease. J Immunol. 1981 Nov;127(5):1817–1822. [PubMed] [Google Scholar]
  6. Koren H. S., Anderson S. J., Fischer D. G., Copeland C. S., Jensen P. J. Regulation of human natural killing. I. The role of monocytes, interferon, and prostaglandins. J Immunol. 1981 Nov;127(5):2007–2013. [PubMed] [Google Scholar]
  7. Pross H. F., Baines M. G. Spontaneous human lymphocyte-mediated cytotoxicity againts tumour target cells. I. The effect of malignant disease. Int J Cancer. 1976 Nov 15;18(5):593–604. doi: 10.1002/ijc.2910180508. [DOI] [PubMed] [Google Scholar]
  8. Steinhauer E. H., Doyle A. T., Reed J., Kadish A. S. Defective natural cytotoxicity in patients with cancer: normal number of effector cells but decreased recycling capacity in patients with advanced disease. J Immunol. 1982 Nov;129(5):2255–2259. [PubMed] [Google Scholar]
  9. Takasugi M., Ramseyer A., Takasugi J. Decline of natural nonselective cell-mediated cytotoxicity in patients with tumor progression. Cancer Res. 1977 Feb;37(2):413–418. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES